Konzept für den Aufbau der sozialwissenschaftlicher Fächer in der Medizin Projet d'intégration des sciences sociales aux programmes d'enseignement de la médecineSCHULLER A; HASFORD J.Medizin Mensch Gesellschaft. 1977, Vol 2, Num 2, pp 108-113Article

Assessing the safety of drugs in pregnancy : The role of prospective cohort studiesIRL, C; HASFORD, J.Drug safety. 2000, Vol 22, Num 3, pp 169-177, issn 0114-5916Article

HUMAN MYOCARDIUM AND PLASMA DIGOXIN CONCENTRATION IN PATIENTS ON LONGTERM DIGOXIN THERAPYLICHEY J; HAVESTATT C; WEINMANN J et al.1978; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; DEU; DA. 1978; VOL. 16; NO 10; PP. 460-462; BIBL. 10 REF.Article

TOEDLICH VERLAUFENE BETA -METHYLDIGOXIN-INTOXIKATION IN SUIZIDALER ABSICHT = INTOXICATION PAR LA BETA -METHYLDIGOXINE DANS UN BUT SUICIDAIRE A EVOLUTION MORTELLERIETBROCK N; WOJAHN H; WEINMANN J et al.1978; DTSCHE MED. WSCHR.; DEU; DA. 1978; VOL. 103; NO 46; PP. 1841-1844; ABS. ENG; BIBL. 35 REF.Article

A population-based European cohort study of persistence in newly diagnosed hypertensive patientsHASFORD, J; MIMRAN, A; SIMONS, W. R et al.Journal of human hypertension. 2002, Vol 16, Num 8, pp 569-575, issn 0950-9240, 7 p.Article

Erythropoetin-bedingte Behandlungskosten von Patienten mit renaler Anämie - Eine Vergleichsstudie zwischen Biosimilars und Originalprodukten = Erythropoietin-induced Treatment Costs in Patients Suffering from Renal Anemia - A Comparison between Biosimilar and Originator DrugsHÖRBRAND, F; ROTTENKOLBER, D; FISCHALECK, J et al.Das Gesundheitswesen (Stuttgart. Thieme). 2014, Vol 76, Num 11, pp 755-756, issn 0941-3790, 2 p.Article

Chronic myelogenous leukemia : progress in chemotherapy and evaluation of prognostic score 1HEHLMANN, R; ANSARI, H; HASFORD, J et al.Seminars in hematology. 1993, Vol 30, Num 3, pp 44-48, issn 0037-1963, SUP3Conference Paper

Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactionsHASFORD, J; GOETTLER, M; MUNTER, K.-H et al.Journal of clinical epidemiology. 2002, Vol 55, Num 9, pp 945-950, issn 0895-4356Article

Rheumatology trials: selection of adequate response variables and their evaluation Essais thérapeutiques en rhumatologie: choix et évaluation des critères de jugementKOEPCKE, W; HASFORD, J; WEBER-FALKENSAMMER, H et al.Revue d'épidémiologie et de santé publique. 1984, Vol 32, Num 3-4, pp 237-242, issn 0398-7620Article

Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are neededHASFORD, J; BRAMLAGE, P; KOCH, G et al.Journal of clinical epidemiology. 2010, Vol 63, Num 12, pp 1298-1304, issn 0895-4356, 7 p.Article

Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments : comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acidSACKMANN, M; PAULETZKI, J; AYDEMIR, U et al.Hepatology (Baltimore, Md.). 1991, Vol 14, Num 6, pp 1136-1141, issn 0270-9139Article

IN-HOSPITAL FALL-RISK SCREENING IN 4,735 GERIATRIC PATIENTS FROM THE LUCAS PROJECTNEUMANN, L; HOFFMANN, V. S; GOLGERT, S et al.The Journal of nutrition, health & aging. 2013, Vol 17, Num 3, pp 264-269, issn 1279-7707, 6 p.Article

Evaluation of the usefulness of dimethicone and/or senna extract in improving the visualization of abdominal organsHELDWEIN, W; SOMMERLATTE, T; HASFORD, J et al.Journal of clinical ultrasound. 1987, Vol 15, Num 7, pp 455-458, issn 0091-2751Article

Persistence with asthma treatment is low in Germany especially for controller medication - a population based study of 483 051 patientsHASFORD, J; URICHER, J; TAUSCHER, M et al.Allergy (Copenhagen). 2010, Vol 65, Num 3, pp 347-354, issn 0105-4538, 8 p.Article

German Multicenter Study Group for Adult ALL (GMALL): recruitment in comparison to ALL incidence and its impact on study resultsDUGAS, M; MESSERER, D; HASFORD, J et al.Annals of hematology (Print). 2003, Vol 82, Num 2, pp 83-87, issn 0939-5555, 5 p.Article

Injection of fibrin tissue adhesive versus laser photocoagulation in the treatment of high-risk bleeding peptic ulcers : A controlled randomized studyHELDWEIN, W; AVENHAUS, W; SCHÖNEKÄS, H et al.Endoscopy (Stuttgart). 1996, Vol 28, Num 9, pp 756-760, issn 0013-726XArticle

How do patients with HIV perceive their general practitioners ?KOCHEN; HASFORD, J; JAGER, H et al.BMJ. British medical journal (International ed.). 1991, Vol 303, Num 6814, pp 1365-1368, issn 0959-8146Article

Gender aspects in chronic myeloid leukemia : long-term results from randomized studiesBERGER, U; MAYWALD, O; LÖFFLER, H et al.Leukemia. 2005, Vol 19, Num 6, pp 984-989, issn 0887-6924, 6 p.Article

Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new scoreHEHLMANN, R; ANSARI, H; HOCHHAUS, A et al.British journal of haematology. 1997, Vol 97, Num 1, pp 76-85, issn 0007-1048Article

Epidemiologische Methoden für die Versorgungsforschung = Epidemiological Methods for Health Services ResearchGLAESKE, G; AUGUSTIN, M; SCHUBERT, I et al.Das Gesundheitswesen (Stuttgart. Thieme). 2009, Vol 71, Num 10, pp 685-693, issn 0941-3790, 9 p.Article

Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemiaBUESCHE, G; FREUND, M; HOLGADO, S et al.Leukemia. 2004, Vol 18, Num 9, pp 1460-1467, issn 0887-6924, 8 p.Article

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia: prospective long-term results from a randomized-controlled trialBUESCHE, G; HEHLMANN, R; KAPPLER, M et al.Leukemia. 2003, Vol 17, Num 12, pp 2444-2453, issn 0887-6924, 10 p.Article

Survival with Bone Marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemiaGALE, R. P; HEHLMANN, R; PASSWEG, J. R et al.Blood. 1998, Vol 91, Num 5, pp 1810-1819, issn 0006-4971Article

Chronic myelogenous leukemia : recent developments in prognostic evaluation and chemotherapyHELMANN, R; HEIMPEL, H; ANSARI, H et al.Leukemia. 1992, Vol 6, pp 110S-114S, issn 0887-6924, SUP3Conference Paper

Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspectsHEHLMANN, R; WILLER, A; TOBLER, A et al.Leukemia. 1997, Vol 11, pp 506-511, issn 0887-6924, SUP3Conference Paper